Point72 Asset Management L.P. Takes $18.89 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Point72 Asset Management L.P. bought a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 212,900 shares of the company's stock, valued at approximately $18,886,000. Point72 Asset Management L.P. owned approximately 1.41% of U.S. Physical Therapy as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. Park Avenue Securities LLC grew its position in U.S. Physical Therapy by 58.1% during the 4th quarter. Park Avenue Securities LLC now owns 4,694 shares of the company's stock worth $416,000 after acquiring an additional 1,725 shares during the last quarter. Albert D Mason Inc. boosted its stake in U.S. Physical Therapy by 1.3% in the fourth quarter. Albert D Mason Inc. now owns 10,596 shares of the company's stock worth $940,000 after purchasing an additional 139 shares in the last quarter. Sugar Maple Asset Management LLC grew its holdings in shares of U.S. Physical Therapy by 60.0% during the fourth quarter. Sugar Maple Asset Management LLC now owns 4,000 shares of the company's stock worth $355,000 after purchasing an additional 1,500 shares during the last quarter. True North Advisors LLC increased its stake in shares of U.S. Physical Therapy by 11.9% in the fourth quarter. True North Advisors LLC now owns 8,756 shares of the company's stock valued at $777,000 after buying an additional 930 shares in the last quarter. Finally, Pacer Advisors Inc. acquired a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at $113,000.

U.S. Physical Therapy Trading Down 2.0%

Shares of NYSE:USPH traded down $1.48 during trading on Friday, hitting $73.47. 17,628 shares of the company's stock were exchanged, compared to its average volume of 110,945. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.12 billion, a P/E ratio of 78.18, a PEG ratio of 3.54 and a beta of 1.44. The firm has a 50-day moving average price of $71.94 and a two-hundred day moving average price of $83.44. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $102.89.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. The firm had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business's quarterly revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.51 EPS. Equities analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.45%. The ex-dividend date is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 82.57%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 2.00% of the company's stock.

Analyst Ratings Changes

Several research analysts recently issued reports on USPH shares. Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Barrington Research reduced their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JPMorgan Chase & Co. dropped their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.